Danco Laboratories LLC, which distributes the abortion pill mifepristone under the brand name Mifeprex, also petitioned the Supreme Court to overturn the appellate court ruling. In a statement, the company accused the courts of imposing restrictions on the drug simply because they do not like it.
“The case presents a serious question: whether courts can disregard constitutional and statutory limits on judicial review of agency action to overrule agency decisions that they dislike,” the statement read. “Danco asks the court to grant review of both the determination that doctors who do not prescribe or want to prescribe Mifeprex have standing and the determination that FDA acted unreasonably in approving the changes in 2016 and 2021 despite the extensive study and other data supporting those decisions.”
Danco’s statement insisted that the company is “confident in the…
Read the full article:
Open the full article on the www.catholicnewsagency.com site
